Mid-term results of Eclipse total shoulder arthroplasty.
| Autor: | Batten TJ; Shoulder & Elbow Unit, Royal Devon & Exeter Hospital, Exeter, UK., Gallacher S; Shoulder & Elbow Unit, Royal Devon & Exeter Hospital, Exeter, UK., Evans JP; College of Medicine & Health, University of Exeter, Exeter, UK., Harding RJ; Shoulder & Elbow Unit, Royal Devon & Exeter Hospital, Exeter, UK., Kitson J; Shoulder & Elbow Unit, Royal Devon & Exeter Hospital, Exeter, UK., Smith CD; Shoulder & Elbow Unit, Royal Devon & Exeter Hospital, Exeter, UK., Thomas WJ; Shoulder & Elbow Unit, Royal Devon & Exeter Hospital, Exeter, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The bone & joint journal [Bone Joint J] 2022 Jan; Vol. 104-B (1), pp. 83-90. |
| DOI: | 10.1302/0301-620X.104B1.BJJ-2021-0869.R2 |
| Abstrakt: | Aims: The use and variety of stemless humeral components in anatomical total shoulder arthroplasty (TSA) have proliferated since their advent in 2004. Early outcomes are reassuring but independent mid-term results are scarce. This independent study reports a consecutive series of 143 Eclipse stemless shoulder prostheses with a minimum five-year (5 to 10) follow-up. Methods: Outcomes of 143 procedures undertaken for all indications in 131 patients were reviewed, with subset analysis of those for osteoarthritis (OA) (n = 99). The primary outcome was the Oxford Shoulder Score (OSS) at a minimum of five years. Secondary outcomes were ranges of motion and radiological analysis of humeral radiolucency, rotator cuff failure, and glenoid loosening. Results: Mean OSS at mean follow-up of 6.67 years (5.0 to 10.74) was 40.12 (9 to 48), with no statistically significant difference between those implanted for a non-OA indication and those for OA (p = 0.056) or time-dependent deterioration between two years and five years (p = 0.206). Ranges of motion significantly improved compared with preoperative findings and were maintained between two and five years with a mean external rotation of 38° (SD 18.1, 0 to 100) and forward elevation of 152° (SD 29.9, 90 to 180). Of those components with radiographs suitable for analysis (n = 83), 23 (28%) were found to have a least one humeral radiolucent line, which were predominantly incomplete, less than 2 mm, and in a single anatomical zone. No humeral components were loose. A radiolucent line was present around 22 (15%) of glenoid components, and 15 (10%) of components had failed. Rotator cuff failure was found in 21 (15%) components. The mean time to either glenoid or rotator cuff failure was greater than three years following implantation. Survivorship was 96.4% (95% CI 91.6 to 98.5, number at risk 128) at five years, and 94.3% (95% CI 88.2 to 97.3, number at risk 76) at seven years, both of which compare favourably with best results taken from available registries. Conclusion: Functional and radiological outcomes of the Eclipse stemless TSA are excellent, with no loose humeral components at minimum five-year follow-up. The presence of radiolucent lines is of interest and requires long-term observation but does not impact on the clinical results. Of the eight revisions required, this was predominantly for glenoid and rotator cuff failure. Cite this article: Bone Joint J 2022;104-B(1):83-90. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|